Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-11

Clinical Trial Update: Low Dose Naltrexone (LDN) Immune Monitoring [NA]

View source ↗

Summary

This clinical trial update reports the completion and posting of results for a low-dose naltrexone immune-monitoring study in fibromyalgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (low-dose) (naltrexone)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Fibromyalgia | NA | Status: COMPLETED | Results posted: 2017-04-11